期刊文献+

增强指数评估动脉僵硬度不如脉搏波速度敏感 被引量:5

The Sensitivity of Augmentation Index and Pulse Way Velocity in Evaluation of Aortic Stiffness in Dialysis Patients
下载PDF
导出
摘要 目的探讨脉搏波速度和增强指数在评估动脉僵硬度方面的敏感性有无差别。方法选取73名持续性非卧床腹膜透析患者为研究对象,测量踝臂指数,根据踝臂指数水平分为踝臂指数≤0.9组和踝臂指数>0.9组。通过外周脉压、中心增强压力、增强指数、中心脉压及颈—股脉搏波速度评估大动脉僵硬度。结果踝臂指数≤0.9组颈—股脉搏波速度明显大于踝臂指数>0.9组(P<0.001),但增强指数在两组之间无明显差别。相关分析显示,颈—股脉搏波速度和踝臂指数存在很好的相关性(P<0.001),增强指数与踝臂指数不存在相关。结论增强指数在评估动脉僵硬度方面没有脉搏波速度敏感,临床上使用增强指数评估动脉僵硬度时需要谨慎。 Aim To study the sensitivity of augmentation index (AI) and pulse way velocity (PWV) in evaluation of aortic stiffness. Methods Seventy-three continuous ambulatory peritoneal dialysis (CAPD) patients in a single center were included in the present study. Ankle-brachial pressure index (ABI) was measured. The patients were classified into ABI≤0.9 group and ABI 〉 0.9 group. Aortic stiffness was assessed by brachial pulse pressure ( PP), central augmentation pressure ( C- AP), M, central PP (C-PP) and carotid-femoral pulse wave velocity (CF-PWV). Results The CF-PWV in ABI≤0.9 group was higher than that of ABI 〉 0.9 group. However, there was no difference in M between the two groups. CF-PWV was positively correlated with ABI ( P 〈 0. 001 ), but M was not correlated with ABI. Conclusions M was not as sensitive as PWV in evaluating aortic stiffness. Therefore, we should be cautious in utilizing AI to evaluate aortic stiffness.
出处 《中国动脉硬化杂志》 CAS CSCD 2008年第1期43-46,共4页 Chinese Journal of Arteriosclerosis
基金 教育部长江学者奖励计划 教育部教育振兴行动计划专项基金(985工程) 院内临床重点项目
关键词 内科学 动脉僵硬度 增强指数 踝臂指数 脉搏波速度 Aortic Stiffness Augmentation Index Ankle-Brachial Index Pulse Wave Velocity
  • 相关文献

参考文献25

  • 1Mitchell GF, Parise H, Benjamin EJ, et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study [J]. Hypertension, 2004, 43:1 239-245.
  • 2Lacy PS, O' Brien DG, Stanley AG, et al. Increased wave velocity is not associated with elevated augmentation index in patients with diabetes [ J ]. J Hypertens,2004,22: 1 937-944.
  • 3Cheng LT, Tang LJ, Cheng L, et al. Limitation of the augmentation index for evaluating arterial stiffness [J]. Hypertens Res, 2007, 30: 713-722.
  • 4Chen CH, Ting CT, Nussbacher A, et al. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure[J]. Hypertension, 1996,27:168-175.
  • 5Chen CH, Nero E, Fetics B, et al. Estimation of central aortic pressure waveform by mathematical transfomation of radial tonometry pressure. Validation of generalized transfer function [J]. Circulation, 1997, 95:1 827-836.
  • 6Rice KL. How to measure ankle/brachial index [J]. Nursing, 2005, 35: 56-57.
  • 7Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application [J]. Hypertension, 1995, 26: 485-490.
  • 8O'Rourke MF, Staessen JA, Vlachopoulos C, et al. Clinical application of arterial stiffness: definitions and reference values [ J ]. Am J Hypertens, 2002, 15: 426-444.
  • 9Pannier BM, Avolio AP, Hoeks A, et al. Methods and devices for measuring arterial compliance in humans[J]. Am J Hypertens, 2002,15: 743-753.
  • 10Blacher J, Guerin AP, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease [J]. Circulation, 1999, 99:2 434-439.

二级参考文献22

共引文献34

同被引文献44

  • 1李佳月,赵玉生,刘丽,李彦华,陈瑞,王琳.老年动脉弹性与颈动脉粥样硬化相关性研究[J].心血管康复医学杂志,2006,15(1):16-18. 被引量:14
  • 2谭静,华琦,闻静,邢绣荣,刘荣坤,杨峥.代谢综合征与动脉僵硬度的关系[J].中国动脉硬化杂志,2006,14(2):167-169. 被引量:20
  • 3Aboyans V, Lacroix P, Ferri e res J, et al. Ankle brachial index: an essential component for the screening, diagnosis and management of peripheral arterial disease[J]. Arch Mal Coeur Vaiss,2004,97(2): 132- 138.
  • 4Pannier BM, Avolio AP, Hoeks A, et al. Methods and devices for measuring arterial compliance in humans[J]. Am J Hypertens,2002, 15(8):743- 753.
  • 5Mitchell GF, Parise H, Benjamin E J, et al. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham heart study[J]. Hypertension,2004, 43(6):1239- 1245.
  • 6US Renal Data System: Annual Data Report, 1998. Bethesda, National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases, 1998.
  • 7Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease [ J ]. Am J Kidney Dis, 1998, 32: S112-S119.
  • 8Johnson DW, Armstrong K, Campbell SB, et al. Metabolic syndrome in severe chronic kidney disease: prevalence, predictors, prognostic significance and effects of risk factor modification [ J ]. Nephrology ( Carlton), 2007, 12 : 391- 398.
  • 9Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II1 )[J]. JAMA, 2001,285 (19): 2 486- 497.
  • 10Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition[ J]. Circulation, 2004, 109: 433-438.

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部